Aberrant Cell Cycle Gene Expression in a Transgenic Mouse Model of Alzheimer’s Disease
Cells · 2026
DOI: 10.3390/cells15020132 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2026. Verfasst von Marika Lanza und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Ferdinando Stagno D'Alcontres 31, 98166 M…. Hauptthemen laut MEDLINE: Alzheimer Disease, Cell Cycle, Gene Expression Regulation. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of University and Research.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer’s disease (AD) is increasingly recognized as a disorder that extends beyond amyloid-β (Aβ) and tau pathology. To this end, growing evidence suggests that aberrant neuronal cell cycle re-entry (CCR) may contribute to neurodegeneration. To investigate this mechanism, we profiled the expression of 84 cell cycle-related genes in the brains of aged APP/PS1 mice, a widely used transgenic model of AD, and compared them with age-matched non-transgenic littermates. Our analysis revealed 32 differentially expressed genes (DEGs), 8 of which exhibited significant changes (fold change > 2, p < 0.05). Several of these DEGs, including CDC7 and CCNC, displayed consistent dysregulation in human AD brains as assessed using the AMP-AD knowledge portal, supporting their translational relevance. Furthermore, integration with miRNA prediction analyses identified candidate post-transcriptional regulators of these DEGs, highlighting novel layers of regulation. Collectively, our results provide the first systematic overview of cell cycle gene dysregulation in aged APP/PS1 mice, establish cross-species concordance with human AD, and propose miRNA–gene interactions as potential contributors to neuronal vulnerability. These findings underscore the importance of cell cycle pathways in AD pathogenesis and point to new avenues for therapeutic exploration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Ferdinando Stagno D'Alcontres 31, 98166 Messina, Italy.
- Department of Clinical and Experimental Medicine, University of Messina, Via Consolare Valeria n.1, 98125 Messina, Italy.
- Department of Chemistry, Biology and Biotechnology, University of Perugia, Via Elce di Sotto, 8, 06123 Perugia, Italy.
- Department of Biomedical Sciences, Dental Sciences, and Morpho-Functional Imaging, University of Messina, Via Consolare Valeria n.1, 98125 Messina, Italy.
- Department of Drug and Health Sciences, University of Catania, 95125 Catania, Italy.
ORCID-Profile: Michele Scuruchi, Emanuela Esposito, Agata Copani, Salvatore Oddo
Förderung
- Italian Ministry of University and Research
Zitieren
APA
Lanza, M., Scuruchi, M., Saitta, A., Basilotta, R., Aliquò, F., Casili, G., Esposito, E., Copani, A., Oddo, S., & Caccamo, A. (2026). Aberrant Cell Cycle Gene Expression in a Transgenic Mouse Model of Alzheimer’s Disease. Cells. https://doi.org/10.3390/cells15020132
Vancouver
Lanza M, Scuruchi M, Saitta A, Basilotta R, Aliquò F, Casili G, et al. Aberrant Cell Cycle Gene Expression in a Transgenic Mouse Model of Alzheimer’s Disease. Cells. 2026. doi:10.3390/cells15020132
BibTeX
@article{Lanza2026,
author = {Lanza, Marika and Scuruchi, Michele and Saitta, Alessandra and Basilotta, Rossella and Aliquò, Federica and Casili, Giovanna and Esposito, Emanuela and Copani, Agata and Oddo, Salvatore and Caccamo, Antonella},
title = {Aberrant Cell Cycle Gene Expression in a Transgenic Mouse Model of Alzheimer’s Disease},
journal = {Cells},
year = {2026},
doi = {10.3390/cells15020132}
}
EUVIMED